Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes (American Journal of Physiology Renal Physiology (2007) 293 (F398-F407) DOI: 10.1152/ajprenal.00050.2007);Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 1, 2007, Pages

  Velez, Juan Carlos Q ^a,b   Bland, Alison M ^b   Arthur, John M ^a,b   Raymond, John R ^a,b   Janech, Michael G ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ACE2; Aminopeptidase A; Angiotensin II; Angiotensin (1 7); Neprilysin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN III; ANGIOTENSIN [1-14]; ANGIOTENSIN [1-7]; ANGIOTENSIN [1-9]; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENZYME INHIBITOR; GLUTAMYL AMINOPEPTIDASE; GLUTAMYL AMINOPEPTIDASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; MEMBRANE METALLOENDOPEPTIDASE INHIBITOR; PEPTIDE; RENIN; RENIN INHIBITOR; UNCLASSIFIED DRUG; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1 9); ANGIOTENSIN I (1-7); ANGIOTENSIN I (1-9); ANGIOTENSIN II, DES ASP(1) DES ARG(2) ILE(5); ANGIOTENSIN II, DES-ASP(1)-DES-ARG(2)-ILE(5)-; DRUG DERIVATIVE; MICROSOMAL AMINOPEPTIDASE; PEPTIDE FRAGMENT; PROTEINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MESANGIUM CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; MASS SPECTROMETRY; METABOLISM; PHYSIOLOGY;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIGENS, CD13; CELLS, CULTURED; GLUTAMYL AMINOPEPTIDASE; HUMANS; MESANGIAL CELLS; MICE; NEPRILYSIN; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PODOCYTES; PROTEASE INHIBITORS; RENIN; RENIN-ANGIOTENSIN SYSTEM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 34548047701     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.zh2-5280-corr.2008     Document Type: Erratum

References (55)

1. Anderson S, Jung FF, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations. Am J Physiol Renal Fluid Electrolyte Physiol 265: F477-F486, 1993.
2. Barisoni L, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 7: 255-259, 2003.
3. Bauer J, Berthold H, Schaefer F, Ehmke H, Parekh N. Quantification of conversion and degradation of circulating angiotensin in rats. Am J Physiol Regul Integr Comp Physiol 277: R412-R418, 1999.
4. Burns KD. Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 36: 449-467, 2000.
5. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 143: 77-89, 2004.
6. Chappell MC, Ferrario CM. ACE and ACE2: their role to balance the expression of angiotensin II and angiotensin-(1-7). Kidney Int 70: 8-10, 2006.
7. Chen Z, Tan F, Erdos EG, Deddish PA. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors. Hypertension 46: 1368-1373, 2005.
8. Correa-Rotter R, Hostetter TH, Manivel JC, Rosenberg ME. Renin expression in renal ablation. Hypertension 20: 483-490, 1992.
9. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int 64: 149-519, 2003.
10. Deschepper CF, Mellon SH, Cumin F, Baxter JD, Ganong WF. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. Proc Natl Acad Sci USA 83: 7552-7556, 1986.
11. Dijkman HB, Assmann KJ, Steenbergen EJ, Wetzels JF. Expression and effect of inhibition of aminopeptidase-A during nephrogenesis. J Histochem Cytochem 54: 253-262, 2006.
12. Dijkman HB, Gerlofs-Nijland ME, van der Laak JA, Wetzels JF, Groenen PJ, Assmann KJ. Podocyte changes after induction of acute albuminuria in mice by anti-aminopeptidase A mAb. Nephron Exp Nephrol 94: e85-e93, 2003.
13. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
14. Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 15: 1-7, 2006.
15. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 65: 30-39, 2004.
16. Elased KM, Cunha TS, Gurley SB, Coffman TM, Morris M. New mass spectrometric assay for angiotensin-converting enzyme 2 activity. Hypertension 47: 1010-1017, 2006.
17. El-Dahr SS, Gomez RA, Gray MS, Peach MJ, Carey RM, Chevalier RL. In situ localization of renin and its mRNA in neonatal ureteral obstruction. Am J Physiol Renal Fluid Electrolyte Physiol 258: F854-F862, 1990.
18. Garcia G, Feng L. ACE2-angiotensin-(1-7) anti-inflammatory pathway during kidney disease (Abstract). J Am Soc Nephrol 17: A-FC023, 2006.
19. Gonzalez W, Soleilhac JM, Fournie-Zaluski MC, Roques BP, Michel JB. Characterization of neutral endopeptidase in vascular cells: modulation of vasoactive peptide levels. Eur J Pharmacol 345: 323-331, 1998.
20. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999.
21. Haulica I, Bild W, Mihaila CN, Ionita T, Boisteanu CP, Neagu B. Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta. J Renin Angiotensin Aldosterone Syst 4: 124-128, 2003.
22. Hostetter TH. Hyperfiltration and glomerulosclerosis. Semin Nephrol 23: 194-199, 2003.
23. Ikehara K, Tada H, Kuboki K, Inokuchi T. Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels. Diabetes Res Clin Pract 59: 25-30, 2003.
24. Janech MG, Chen R, Klein J, Nowak MW, McFee W, Paul R, Fitzgibbon W, Ploth DW. Molecular and functional characterization of a urea transporter from the kidney of a short-finned pilot whale. Am J Physiol Regul Integr Comp Physiol 282: R1490-R1500, 2002.
25. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52: 11-34, 2000.
26. Largo R, Gomez-Garre D, Soto K, Marron B, Blanco J, Gazapo RM, Plaza JJ, Egido J. Angiotensin-converting enzyme is up-regulated in the proximal tubules of rats with intense proteinuria. Hypertension 33: 732-739, 1999.
27. Leehey DJ, Isreb MA, Marcic S, Singh AK, Singh R. Effect of high glucose on superoxide in human mesangial cells: role of angiotensin II. Nephron Exp Nephrol 100: e46-e53, 2005.
28. Lewis EJ, Hunsicker L, Bain R, Rhode R. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462, 1993.
29. Li N, Zimpelmann J, Cheng K, Wilkins JA, Burns KD. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288: F353-F362, 2005.
30. Liebau MC, Lang D, Bohm J, Endlich N, Bek MJ, Witherden I, Mathieson PW, Saleem MA, Pavenstadt H, Fischer KG. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 290: F710-F719, 2006.
31. Maschio G, Alberti D, Janin G, Locatelli F, Mann J, Motolese L, Ponticelli C, Ritz E, Zucchelli P. Effect of the angiotensin-concerting enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334: 939-945, 1996.
32. 2 and prostacyclin. Kidney Int 38: 232-239, 1990.
33. Mizuiri S, Yoshikawa H, Tanegashima M, Miyagi M, Kobayashi M, Sakai K, Hayashi I, Aikawa A, Ohara T, Hasegawa A. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy. Am J Kidney Dis 31: 301-307, 1998.
34. Morris BJ, Reid IA. A "renin-like" enzymatic action of cathepsin D and the similarity in subcellular distributions of "renin-like" activity and cathepsin D in the midbrain of dogs. Endocrinology 103: 1289-1296, 1978.
35. Mundel P, Reiser J, Zuniga Mejia Borja A, Pavenstädt H, Davidson G, Kriz W, Zeller R. Rearrangements of cytoskeleton and cell contacts induce process formation and postmitotic differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997.
36. Navar LG, Rosivall L, Carmines PK, Oparil S. Effects of locally formed angiotensin II on renal hemodynamics. Fed Proc 45: 1448-1453, 1986.
37. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 13: 2207-2212, 2002.
38. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, Khokha R, Crackower MA, Backx PH, Penninger JM, Scholey JW. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am J Pathol 168: 1808-1820, 2006.
39. Plovsing RR, Wamberg C, Sandgaard NC, Simonsen JA, Holstein-Rathlou NH, Hoilund-Carlsen PF, Bie P. Effects of truncated angiotensins in humans after double blockade of the renin system. Am J Physiol Regul Integr Comp Physiol 285: R981-R991, 2003.
40. Prieto I, Hermoso F, Gasparo M, Vargas F, Alba F, Segarra AB, Banegas I, Ramirez M. Angiotensinase activities in the kidney of renovascular hypertensive rats. Peptides 24: 755-760, 2003.
41. Ren Y, Garvin JL, Carretero OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 39: 799-802, 2002.
42. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383: 45-51, 2004.
43. Sampaio W, Nascimento A, Santos R. Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats. Am J Physiol Heart Circ Physiol 284: H1985-H1994, 2003.
44. Sequeira Lopez ML, Pentz ES, Nomasa T, Smithies O, Gomez RA. Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Dev Cell 6: 719-728, 2004.
45. Shaltout HA, Westwood B, Averill DB, Ferrario CM, Figueroa J, Diz DI, Rose JC, Chappell MC. Angiotensin metabolism in renal proximal tubules, urine and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292: F82-F91, 2007.
46. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69: 2131-2147, 2006.
47. Sharma R, Sharma M, Reddy S, Savin VJ, Nagaria AM, Wiegmann TB. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes. Front Biosci 11: 968-976, 2006.
48. Singh R, Singh AK, Alavi N, Leehey DJ. Mechanism of increased angiotensin II levels in glomerular mesangial cells cultured in high glucose. J Am Soc Nephrol 14: 873-880, 2003.
49. Singh R, Singh AK, Leehey DJ. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli. Am J Physiol Renal Physiol 288: F1183-F1190, 2005.
50. Vidotti DB, Casarini DE, Cristovam PC, Leite CA, Schor N, Boim MA. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am J Physiol Renal Physiol 286: F1039-F1045, 2004.
51. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, Turner AJ. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J Biol Chem 280: 39353-39362, 2005.
52. Wolf G. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-β pathway. Kidney Int 70: 1914-1919, 2006.
53. Wolf G, Wenzel U, Assmann KJ, Stahl RA. Renal expression of aminopeptidase A in rats with two-kidney, one-clip hypertension. Nephrol Dial Transplant 15: 1935-1942, 2000.
54. Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 17: 3067-3075, 2006.
55. Zisman L, Meixell G, Bristow M, Canver C. Angiotensin-(1-7) formation in the intact human heart. Circulation 108: 1679-1681, 2003.